AGREEMENT CONTAINING CONSENT ORDERSMay 5th, 2020
FiledMay 5th, 2020The Federal Trade Commission (“Commission”), having initiated an investigation of the proposed acquisition by Proposed Respondent Prestige Brands Holdings, Inc. (“Prestige”) of the voting securities of Proposed Respondent Insight Pharmaceuticals Corporation (“Insight”), hereinafter “Proposed Respondents”, and it now appearing that Proposed Respondents are willing to enter into this Agreement Containing Consent Orders (“Consent Agreement”) to divest certain assets and providing for other relief: